Pre-frontal cortex processing disorder speech, gait and limb impairments treatment

• 收藏
• 分享

专利权人:

GILROSE PHARMACEUTICALS, LLC

发明人:

Roseman Bruce,Kaplan Gilla

申请号：

US201715596075

公开号：

US10085414(B2)

申请日:

2017.05.16

申请国别(地区):

美国

年份:

2018

代理人:

Feldman Marvin`Lackenback Siegel, LLP

摘要：

A methylphenidate, particularly including dextro-threo-methylphenidate, is administered to a subject to treat a speech, gait or limb impairment secondary to a genetically acquired pre-frontal cortex processing disease or disorder, particularly including multiple sclerosis, cerebral palsy, Angelman syndrome, Rett syndrome and Fragile-X syndrome.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/